UCHL3 and prostate cancer: By contrast, UCHL3 is reduced in metastatic prostate cancer cell lines, and knockdown of UCHL3 promotes epithelial-to-mesenchymal transition (EMT), contributing to cancer cell invasion and metastasis (102).